Decision Diagnostics Corp. DECN OTC

Other OTC • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score

32/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Decision Diagnostics Corp. (DECN) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 29/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

32/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

14/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — DECN

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2013	$-0.36	$1.44M	$-7.95M	-550.3%
2014	$-0.08	$426.53K	$-1.84M	-431.6%
2015	$-0.04	$292.03K	$-2.21M	-755.5%
2016	$-0.04	$725.48K	$-2.97M	-409%
2017	$-0.03	$1.88M	$-2.99M	-159.1%
2018	$-0.02	$2.24M	$-2.24M	-100.2%
2019	$-0.02	$2.38M	$-3.13M	-131.7%
2020	$-0.11	$1.98M	$-29.67M	-1499.1%
2021	$0.00	$0.00	$0.00	-
2022	$0.00	$0.00	$0.00	-